XML 13 R2.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 193,017 $ 386,535
Marketable securities 603,478 499,950
Total cash, cash equivalents, and marketable securities 796,495 886,485
Accounts and accrued receivable 20,003 38,593
Restricted cash 25,000 25,000
Other current assets 99,155 75,413
Total current assets 940,653 1,025,491
Long-term assets:    
Property and equipment, net 233,187 217,255
Intangible assets, net 128,845 131,502
Goodwill 47,806 47,806
Investments in and loans to equity accounted investees 57,583 72,522
Other long-term assets 89,845 46,331
Total long-term assets 557,266 515,416
Total assets 1,497,919 1,540,907
Current liabilities:    
Accounts payable and other liabilities 31,814 33,150
Current portion of contingent consideration payable 42,876 44,211
Accrued royalties payable 3,094 19,347
Deferred revenue 11,807 21,612
Total current liabilities 89,591 118,320
Long-term liabilities:    
Operating lease liability 77,265 76,675
Deferred revenue 25,416 19,516
Deferred grant funding 45,026 40,801
Contingent consideration payable 15,733 16,054
Deferred tax liability 33,426 33,178
Other long-term liabilities 2,962 3,086
Total long-term liabilities 199,828 189,310
Total liabilities 289,419 307,630
Commitments and contingencies
Common stock, no par value (USD per share) $ 0 $ 0
Shareholders' equity:    
Common shares: no par value, unlimited authorized shares at December 31, 2022 and March 31, 2023: 286,851,595 and 288,426,514 shares issued and outstanding at December 31, 2022 and March 31, 2023, respectively $ 742,816 $ 734,365
Additional paid-in capital 81,630 74,118
Accumulated other comprehensive (loss) (2,021) (1,391)
Accumulated earnings 386,075 426,185
Total shareholders' equity 1,208,500 1,233,277
Total liabilities and shareholders' equity $ 1,497,919 $ 1,540,907